Deerfield Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Deerfield Management’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-279,204	Closed	-$1.45M	–	134
2015 Q3	$1.45M	Hold	279,204	–	–	0.06%	120
2015 Q2	$1.9M	Hold	279,204	–	–	0.06%	108
2015 Q1	$1.99M	Sell	279,204 -73,180	-21%	-$504K	0.06%	101
2014 Q4	$2.63M	Sell	352,384 -57,479	-14%	-$488K	0.09%	93
2014 Q3	$3.79M	Buy	409,863 +34,863	+9%	+$471K	0.14%	101
2014 Q2	$6.99M	Buy	+375,000	New	+$6.37M	0.28%	76
2014 Q1	–	Sell	-225,000	Closed	-$2.51M	–	144
2013 Q4	$2.51M	Buy	+225,000	New	+$2.68M	0.13%	86

Other funds holding KIN

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Deerfield Management's KIN Position: Q4 2015 in Review

Deerfield Management sold out of Kindred Biosciences, Inc. (KIN) in Q4 2015, closing a stake of 279,204 shares — an estimated $1.45M sold.

Deerfield Management first reported a position in KIN in Q4 2013 and held it in 7 quarters. The position peaked at $6.99M in Q2 2014. 50 funds tracked by Wall St. Rank hold KIN as of Q4 2015.

Deerfield Management reported no remaining Kindred Biosciences, Inc. position as of Q4 2015 after selling out during the quarter.
Deerfield Management sold 279,204 Kindred Biosciences, Inc. shares in Q4 2015, an estimated $1.45M.
Deerfield Management first reported a position in Kindred Biosciences, Inc. in Q4 2013 and held it in 7 quarters.
Deerfield Management's Kindred Biosciences, Inc. position peaked at $6.99M in Q2 2014.
50 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2015.

Based on Deerfield Management's 13F filing for Q4 2015, filed 16 Feb 2016.